UniProt ID | BACD2_HUMAN | |
---|---|---|
UniProt AC | Q13829 | |
Protein Name | BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 | |
Gene Name | TNFAIP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 316 | |
Subcellular Localization | Cytoplasm. Nucleus. Endosome. Colocalizes with RHOB in endosomes. | |
Protein Description | Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex involved in regulation of cytoskeleton structure. The BCR(TNFAIP1) E3 ubiquitin ligase complex mediates the ubiquitination of RHOA, leading to its degradation by the proteasome, thereby regulating the actin cytoskeleton and cell migration. Its interaction with RHOB may regulate apoptosis. May enhance the PCNA-dependent DNA polymerase delta activity.. | |
Protein Sequence | MSGDTCLCPASGAKPKLSGFKGGGLGNKYVQLNVGGSLYYTTVRALTRHDTMLKAMFSGRMEVLTDKEGWILIDRCGKHFGTILNYLRDDTITLPQNRQEIKELMAEAKYYLIQGLVNMCQSALQDKKDSYQPVCNIPIITSLKEEERLIESSTKPVVKLLYNRSNNKYSYTSNSDDHLLKNIELFDKLSLRFNGRVLFIKDVIGDEICCWSFYGQGRKLAEVCCTSIVYATEKKQTKVEFPEARIYEETLNVLLYETPRVPDNSLLEATSRSRSQASPSEDEETFELRDRVRRIHVKRYSTYDDRQLGHQSTHRD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Phosphorylation | DTCLCPASGAKPKLS CCEEECCCCCCCCCC | 25.15 | 25159151 | |
14 | Ubiquitination | LCPASGAKPKLSGFK EECCCCCCCCCCCCC | 46.33 | 33845483 | |
16 | Ubiquitination | PASGAKPKLSGFKGG CCCCCCCCCCCCCCC | 55.36 | 23000965 | |
21 | Ubiquitination | KPKLSGFKGGGLGNK CCCCCCCCCCCCCCC | 61.24 | 21890473 | |
21 | Ubiquitination | KPKLSGFKGGGLGNK CCCCCCCCCCCCCCC | 61.24 | 21890473 | |
21 | Ubiquitination | KPKLSGFKGGGLGNK CCCCCCCCCCCCCCC | 61.24 | 23000965 | |
29 | Phosphorylation | GGGLGNKYVQLNVGG CCCCCCCEEEEECCC | 9.45 | 25072903 | |
37 | Phosphorylation | VQLNVGGSLYYTTVR EEEECCCEEEHHHHH | 13.79 | 25072903 | |
39 | Phosphorylation | LNVGGSLYYTTVRAL EECCCEEEHHHHHHH | 10.64 | 25072903 | |
40 | Phosphorylation | NVGGSLYYTTVRALT ECCCEEEHHHHHHHH | 10.96 | 25072903 | |
41 | Phosphorylation | VGGSLYYTTVRALTR CCCEEEHHHHHHHHC | 12.78 | 25072903 | |
42 | Phosphorylation | GGSLYYTTVRALTRH CCEEEHHHHHHHHCC | 7.59 | 25072903 | |
51 | Ubiquitination | RALTRHDTMLKAMFS HHHHCCHHHHHHHHH | 20.48 | - | |
51 | Phosphorylation | RALTRHDTMLKAMFS HHHHCCHHHHHHHHH | 20.48 | - | |
58 | Phosphorylation | TMLKAMFSGRMEVLT HHHHHHHHCCCEEEE | 16.65 | - | |
64 | Ubiquitination | FSGRMEVLTDKEGWI HHCCCEEEECCCCEE | 3.06 | - | |
67 | Ubiquitination | RMEVLTDKEGWILID CCEEEECCCCEEEEE | 53.55 | 21906983 | |
78 | Ubiquitination | ILIDRCGKHFGTILN EEEECCCCCHHHHHH | 39.11 | - | |
102 | Ubiquitination | PQNRQEIKELMAEAK CCCHHHHHHHHHHHH | 44.00 | 32015554 | |
127 | Ubiquitination | CQSALQDKKDSYQPV HHHHHHCCCCCCCCC | 45.58 | 32015554 | |
130 | Ubiquitination | ALQDKKDSYQPVCNI HHHCCCCCCCCCCCC | 34.25 | - | |
131 | Ubiquitination | LQDKKDSYQPVCNIP HHCCCCCCCCCCCCC | 27.28 | - | |
142 | Phosphorylation | CNIPIITSLKEEERL CCCCEEECCCHHHHH | 27.34 | - | |
144 | Ubiquitination | IPIITSLKEEERLIE CCEEECCCHHHHHHH | 63.95 | 32015554 | |
155 | Ubiquitination | RLIESSTKPVVKLLY HHHHCCCCCHHHHHE | 37.45 | 32015554 | |
159 | Ubiquitination | SSTKPVVKLLYNRSN CCCCCHHHHHEECCC | 32.77 | 29967540 | |
162 | Phosphorylation | KPVVKLLYNRSNNKY CCHHHHHEECCCCCE | 20.97 | - | |
168 | Ubiquitination | LYNRSNNKYSYTSNS HEECCCCCEEECCCC | 39.56 | 32015554 | |
169 | Phosphorylation | YNRSNNKYSYTSNSD EECCCCCEEECCCCC | 14.72 | 29496907 | |
170 | Phosphorylation | NRSNNKYSYTSNSDD ECCCCCEEECCCCCC | 24.44 | 29496907 | |
181 | Ubiquitination | NSDDHLLKNIELFDK CCCCCHHHHHHHHHH | 63.34 | 29967540 | |
188 | Ubiquitination | KNIELFDKLSLRFNG HHHHHHHHHHHEECC | 32.42 | 21963094 | |
190 | Phosphorylation | IELFDKLSLRFNGRV HHHHHHHHHEECCEE | 24.20 | 24719451 | |
234 | Ubiquitination | SIVYATEKKQTKVEF HHHHHCCCCCCCCCC | 45.91 | 21963094 | |
235 | Ubiquitination | IVYATEKKQTKVEFP HHHHCCCCCCCCCCC | 57.90 | 22817900 | |
237 | Phosphorylation | YATEKKQTKVEFPEA HHCCCCCCCCCCCCH | 46.03 | - | |
238 | Ubiquitination | ATEKKQTKVEFPEAR HCCCCCCCCCCCCHH | 36.95 | 22817900 | |
250 | Phosphorylation | EARIYEETLNVLLYE CHHHHHHHHHHHEEC | 16.22 | 22210691 | |
256 | Phosphorylation | ETLNVLLYETPRVPD HHHHHHEECCCCCCC | 17.37 | - | |
265 | Phosphorylation | TPRVPDNSLLEATSR CCCCCCCCHHHHHHC | 41.53 | 28555341 | |
270 | Phosphorylation | DNSLLEATSRSRSQA CCCHHHHHHCCCCCC | 18.46 | 22210691 | |
271 | Phosphorylation | NSLLEATSRSRSQAS CCHHHHHHCCCCCCC | 34.99 | 22210691 | |
273 | Phosphorylation | LLEATSRSRSQASPS HHHHHHCCCCCCCCC | 35.73 | 24732914 | |
275 | Phosphorylation | EATSRSRSQASPSED HHHHCCCCCCCCCCC | 31.20 | 29255136 | |
278 | Phosphorylation | SRSRSQASPSEDEET HCCCCCCCCCCCHHH | 22.71 | 29255136 | |
280 | Phosphorylation | SRSQASPSEDEETFE CCCCCCCCCCHHHHH | 56.00 | 29255136 | |
285 | Phosphorylation | SPSEDEETFELRDRV CCCCCHHHHHHHHHH | 21.99 | 23663014 | |
301 | Phosphorylation | RIHVKRYSTYDDRQL EEEEEEECCCCCHHH | 25.23 | 30576142 | |
302 | Phosphorylation | IHVKRYSTYDDRQLG EEEEEECCCCCHHHC | 23.26 | 27251275 | |
303 | Phosphorylation | HVKRYSTYDDRQLGH EEEEECCCCCHHHCC | 15.20 | 29214152 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
278 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
280 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
280 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
280 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
280 | S | Phosphorylation |
| 18669648 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BACD2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BACD3_HUMAN | KCTD10 | physical | 22810651 | |
RIN3_HUMAN | RIN3 | physical | 22810651 | |
CUL3_HUMAN | CUL3 | physical | 22810651 | |
CSK2B_HUMAN | CSNK2B | physical | 19851886 | |
PCNA_HUMAN | PCNA | physical | 19851886 | |
KDM1A_HUMAN | KDM1A | physical | 23455924 | |
SUV91_HUMAN | SUV39H1 | physical | 23455924 | |
RHOA_HUMAN | RHOA | physical | 19782033 | |
BACD2_HUMAN | TNFAIP1 | physical | 25416956 | |
CUL3_HUMAN | CUL3 | physical | 25416956 | |
HAT1_HUMAN | HAT1 | physical | 25416956 | |
STK16_HUMAN | STK16 | physical | 25416956 | |
RPAC1_HUMAN | POLR1C | physical | 25416956 | |
EPMIP_HUMAN | EPM2AIP1 | physical | 25416956 | |
CAN7_HUMAN | CAPN7 | physical | 25416956 | |
EXOS5_HUMAN | EXOSC5 | physical | 25416956 | |
CARD9_HUMAN | CARD9 | physical | 25416956 | |
ARMC7_HUMAN | ARMC7 | physical | 25416956 | |
BACD1_HUMAN | KCTD13 | physical | 25416956 | |
TBB4A_HUMAN | TUBB4A | physical | 23912453 | |
HS71L_HUMAN | HSPA1L | physical | 26186194 | |
FLNC_HUMAN | FLNC | physical | 26186194 | |
BAG3_HUMAN | BAG3 | physical | 26186194 | |
BACD3_HUMAN | KCTD10 | physical | 26186194 | |
BACD3_HUMAN | KCTD10 | physical | 28514442 | |
FLNC_HUMAN | FLNC | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"CK2 phosphorylates TNFAIP1 to affect its subcellular localization andinteraction with PCNA."; Yang L., Liu N., Hu X., Zhang W., Wang T., Li H., Zhang B., Xiang S.,Zhou J., Zhang J.; Mol. Biol. Rep. 37:2967-2973(2010). Cited for: INTERACTION WITH CSNK2B AND PCNA, PHOSPHORYLATION AT SER-280,SUBCELLULAR LOCATION, AND MUTAGENESIS OF SER-142; THR-237; SER-265;SER-278 AND SER-280. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-278 AND SER-280, ANDMASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-278, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-285, AND MASSSPECTROMETRY. |